Psychedelics Weekly – The Church of Psilomethoxin Controversy, Psychedelics for Long COVID, and The Growth of Bicycle Day

Psychedelics Today - Podcast készítő Psychedelics Today

In this episode of Psychedelics Weekly, Joe and Kyle once again record in person, diving into novel compounds, changing opinions, Bicycle Day, and more.  They start by dissecting a very recent controversy around The Church of Psilomethoxin and whether the sacrament they label as psilomethoxin – supposedly created by adding 5-MeO-DMT to the substrate of cultivated Psilocybe mushrooms – actually contains any psilomethoxin in it. Usona Institute published a paper last week reporting on their analysis of a sample they allegedly collected from the Church, which only showed what we’d see in a sample of a typical psilocybin-containing mushroom. While the Church has issues with Usona’s data collection, analytical methods, and motives, they also reiterate a main component of the church: that their "claims to the existence of Psilomethoxin, at this time, are solely based on faith," and bolstered by their “own direct experiences with the Sacrament.” It’s a very interesting story that touches on faith, consent, personal safety, and the harms of the drug war, which Joe covered extensively in a Twitter Space last night with Andrew Gallimore and the writer of a very critical article, Mario de la Fuente.  They also discuss:  -a Time magazine article about the mystery of Long COVID, and how many believe the anti-inflammatory and neuroplastic benefits of psychedelics could be the answer;  -how Bicycle Day may soon become more popular than 4/20, likely due to society’s warmer reception to the life-changing effects of psychedelics (as opposed to their propagandized and unmoving beliefs about cannabis);  -how some analysts believe that seven in 10 ketamine companies will likely face financial challenges as the industry grows too quickly;  and why Snoop Dogg apparently microwaves blunts before smoking them (and does that actually do anything?). www.psychedelicstoday.com

Visit the podcast's native language site